Medical Devices & Consumables
Drug of Abuse (DOA) Testing Consumables - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 558374
- Pages: 93
- Figures: 165
- Views: 1
The drug of abuse test is an immunoassay based on the principle of competitive binding. This report mainly focuses on drug of abuse (DOA) testing consumables market.
The global market for Drug of Abuse (DOA) Testing Consumables was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Consumables accounted for a major share of the drug of abuse testing market, over 60%, as they can be quickly used for on-site testing of drugs. Consumables can only be used once, and the shelf life is extremely short, requiring repeated purchases. North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing Consumables, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug of Abuse (DOA) Testing Consumables by region & country, by Type, and by Application.
The Drug of Abuse (DOA) Testing Consumables market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing Consumables.
Market Segmentation
By Company
Siemens AG
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type:
Rapid Test Kits
Assay Kits and Reagents
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug of Abuse (DOA) Testing Consumables manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug of Abuse (DOA) Testing Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug of Abuse (DOA) Testing Consumables in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Drug of Abuse (DOA) Testing Consumables was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Consumables accounted for a major share of the drug of abuse testing market, over 60%, as they can be quickly used for on-site testing of drugs. Consumables can only be used once, and the shelf life is extremely short, requiring repeated purchases. North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing Consumables, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug of Abuse (DOA) Testing Consumables by region & country, by Type, and by Application.
The Drug of Abuse (DOA) Testing Consumables market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing Consumables.
Market Segmentation
By Company
Siemens AG
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type:
Rapid Test Kits
Assay Kits and Reagents
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug of Abuse (DOA) Testing Consumables manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug of Abuse (DOA) Testing Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug of Abuse (DOA) Testing Consumables in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Drug of Abuse (DOA) Testing Consumables Product Introduction
1.2 Global Drug of Abuse (DOA) Testing Consumables Market Size Forecast
1.3 Drug of Abuse (DOA) Testing Consumables Market Trends & Drivers
1.3.1 Drug of Abuse (DOA) Testing Consumables Industry Trends
1.3.2 Drug of Abuse (DOA) Testing Consumables Market Drivers & Opportunity
1.3.3 Drug of Abuse (DOA) Testing Consumables Market Challenges
1.3.4 Drug of Abuse (DOA) Testing Consumables Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug of Abuse (DOA) Testing Consumables Players Revenue Ranking (2023)
2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2019-2024)
2.3 Key Companies Drug of Abuse (DOA) Testing Consumables Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug of Abuse (DOA) Testing Consumables Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing Consumables
2.6 Drug of Abuse (DOA) Testing Consumables Market Competitive Analysis
2.6.1 Drug of Abuse (DOA) Testing Consumables Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug of Abuse (DOA) Testing Consumables Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapid Test Kits
3.1.2 Assay Kits and Reagents
3.1.3 Others
3.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type
3.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Type (2019-2030)
3.2.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Workplace
4.1.4 At-Home
4.1.5 Others
4.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application
4.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Application (2019-2030)
4.2.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region
5.1.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024)
5.1.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030)
5.1.4 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.2.2 North America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.3.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.4.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.5.2 South America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value
6.3 United States
6.3.1 United States Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.3.2 United States Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.4.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.5.2 China Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.6.2 Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.7.2 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.8.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.9.2 India Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens AG
7.1.1 Siemens AG Profile
7.1.2 Siemens AG Main Business
7.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.1.4 Siemens AG Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens AG Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.2.4 Merck Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.3.4 Roche Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Profile
7.4.2 Thermo Fisher Scientific Main Business
7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Profile
7.5.2 Bio-Rad Main Business
7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.5.4 Bio-Rad Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.6.4 Abbott Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Profile
7.7.2 Quest Diagnostics Main Business
7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.7.5 Quest Diagnostics Recent Developments
7.8 Psychemedics
7.8.1 Psychemedics Profile
7.8.2 Psychemedics Main Business
7.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.8.4 Psychemedics Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.8.5 Psychemedics Recent Developments
8 Industry Chain Analysis
8.1 Drug of Abuse (DOA) Testing Consumables Industrial Chain
8.2 Drug of Abuse (DOA) Testing Consumables Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug of Abuse (DOA) Testing Consumables Sales Model
8.5.2 Sales Channel
8.5.3 Drug of Abuse (DOA) Testing Consumables Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Drug of Abuse (DOA) Testing Consumables Product Introduction
1.2 Global Drug of Abuse (DOA) Testing Consumables Market Size Forecast
1.3 Drug of Abuse (DOA) Testing Consumables Market Trends & Drivers
1.3.1 Drug of Abuse (DOA) Testing Consumables Industry Trends
1.3.2 Drug of Abuse (DOA) Testing Consumables Market Drivers & Opportunity
1.3.3 Drug of Abuse (DOA) Testing Consumables Market Challenges
1.3.4 Drug of Abuse (DOA) Testing Consumables Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug of Abuse (DOA) Testing Consumables Players Revenue Ranking (2023)
2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2019-2024)
2.3 Key Companies Drug of Abuse (DOA) Testing Consumables Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug of Abuse (DOA) Testing Consumables Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing Consumables
2.6 Drug of Abuse (DOA) Testing Consumables Market Competitive Analysis
2.6.1 Drug of Abuse (DOA) Testing Consumables Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug of Abuse (DOA) Testing Consumables Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapid Test Kits
3.1.2 Assay Kits and Reagents
3.1.3 Others
3.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type
3.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Type (2019-2030)
3.2.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Workplace
4.1.4 At-Home
4.1.5 Others
4.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application
4.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Application (2019-2030)
4.2.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region
5.1.1 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024)
5.1.3 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030)
5.1.4 Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.2.2 North America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.3.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.4.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.5.2 South America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value
6.3 United States
6.3.1 United States Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.3.2 United States Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.4.2 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.5.2 China Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.6.2 Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.7.2 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.8.2 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug of Abuse (DOA) Testing Consumables Sales Value, 2019-2030
6.9.2 India Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug of Abuse (DOA) Testing Consumables Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Siemens AG
7.1.1 Siemens AG Profile
7.1.2 Siemens AG Main Business
7.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.1.4 Siemens AG Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.1.5 Siemens AG Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.2.4 Merck Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.3.4 Roche Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Profile
7.4.2 Thermo Fisher Scientific Main Business
7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Profile
7.5.2 Bio-Rad Main Business
7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.5.4 Bio-Rad Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.6.4 Abbott Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Profile
7.7.2 Quest Diagnostics Main Business
7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.7.5 Quest Diagnostics Recent Developments
7.8 Psychemedics
7.8.1 Psychemedics Profile
7.8.2 Psychemedics Main Business
7.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
7.8.4 Psychemedics Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) & (2019-2024)
7.8.5 Psychemedics Recent Developments
8 Industry Chain Analysis
8.1 Drug of Abuse (DOA) Testing Consumables Industrial Chain
8.2 Drug of Abuse (DOA) Testing Consumables Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug of Abuse (DOA) Testing Consumables Sales Model
8.5.2 Sales Channel
8.5.3 Drug of Abuse (DOA) Testing Consumables Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Drug of Abuse (DOA) Testing Consumables Market Trends
Table 2. Drug of Abuse (DOA) Testing Consumables Market Drivers & Opportunity
Table 3. Drug of Abuse (DOA) Testing Consumables Market Challenges
Table 4. Drug of Abuse (DOA) Testing Consumables Market Restraints
Table 5. Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Drug of Abuse (DOA) Testing Consumables Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drug of Abuse (DOA) Testing Consumables Product Type
Table 9. Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing Consumables
Table 10. Global Drug of Abuse (DOA) Testing Consumables Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024) & (%)
Table 27. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value, (2025-2030) & (US$ Million)
Table 31. Siemens AG Basic Information List
Table 32. Siemens AG Description and Business Overview
Table 33. Siemens AG Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Siemens AG (2019-2024)
Table 35. Siemens AG Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. Thermo Fisher Scientific Basic Information List
Table 47. Thermo Fisher Scientific Description and Business Overview
Table 48. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Thermo Fisher Scientific (2019-2024)
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. Bio-Rad Basic Information List
Table 52. Bio-Rad Description and Business Overview
Table 53. Bio-Rad Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Bio-Rad (2019-2024)
Table 55. Bio-Rad Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. Quest Diagnostics Basic Information List
Table 62. Quest Diagnostics Description and Business Overview
Table 63. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Quest Diagnostics (2019-2024)
Table 65. Quest Diagnostics Recent Developments
Table 66. Psychemedics Basic Information List
Table 67. Psychemedics Description and Business Overview
Table 68. Psychemedics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Psychemedics (2019-2024)
Table 70. Psychemedics Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Drug of Abuse (DOA) Testing Consumables Downstream Customers
Table 74. Drug of Abuse (DOA) Testing Consumables Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drug of Abuse (DOA) Testing Consumables Product Picture
Figure 2. Global Drug of Abuse (DOA) Testing Consumables Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 4. Drug of Abuse (DOA) Testing Consumables Report Years Considered
Figure 5. Global Drug of Abuse (DOA) Testing Consumables Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug of Abuse (DOA) Testing Consumables Revenue in 2023
Figure 7. Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rapid Test Kits Picture
Figure 9. Assay Kits and Reagents Picture
Figure 10. Others Picture
Figure 11. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Drug of Abuse (DOA) Testing Consumables Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Laboratories
Figure 15. Product Picture of Workplace
Figure 16. Product Picture of At-Home
Figure 17. Product Picture of Others
Figure 18. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Drug of Abuse (DOA) Testing Consumables Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value (%), (2019-2030)
Figure 31. United States Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 37. China Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 39. China Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 49. India Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 51. India Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 52. Drug of Abuse (DOA) Testing Consumables Industrial Chain
Figure 53. Drug of Abuse (DOA) Testing Consumables Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Table 1. Drug of Abuse (DOA) Testing Consumables Market Trends
Table 2. Drug of Abuse (DOA) Testing Consumables Market Drivers & Opportunity
Table 3. Drug of Abuse (DOA) Testing Consumables Market Challenges
Table 4. Drug of Abuse (DOA) Testing Consumables Market Restraints
Table 5. Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Drug of Abuse (DOA) Testing Consumables Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drug of Abuse (DOA) Testing Consumables Product Type
Table 9. Key Companies Time to Begin Mass Production of Drug of Abuse (DOA) Testing Consumables
Table 10. Global Drug of Abuse (DOA) Testing Consumables Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2019-2024) & (%)
Table 27. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value, (2025-2030) & (US$ Million)
Table 31. Siemens AG Basic Information List
Table 32. Siemens AG Description and Business Overview
Table 33. Siemens AG Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Siemens AG (2019-2024)
Table 35. Siemens AG Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. Thermo Fisher Scientific Basic Information List
Table 47. Thermo Fisher Scientific Description and Business Overview
Table 48. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Thermo Fisher Scientific (2019-2024)
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. Bio-Rad Basic Information List
Table 52. Bio-Rad Description and Business Overview
Table 53. Bio-Rad Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Bio-Rad (2019-2024)
Table 55. Bio-Rad Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. Quest Diagnostics Basic Information List
Table 62. Quest Diagnostics Description and Business Overview
Table 63. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Quest Diagnostics (2019-2024)
Table 65. Quest Diagnostics Recent Developments
Table 66. Psychemedics Basic Information List
Table 67. Psychemedics Description and Business Overview
Table 68. Psychemedics Drug of Abuse (DOA) Testing Consumables Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Consumables Business of Psychemedics (2019-2024)
Table 70. Psychemedics Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Drug of Abuse (DOA) Testing Consumables Downstream Customers
Table 74. Drug of Abuse (DOA) Testing Consumables Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drug of Abuse (DOA) Testing Consumables Product Picture
Figure 2. Global Drug of Abuse (DOA) Testing Consumables Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 4. Drug of Abuse (DOA) Testing Consumables Report Years Considered
Figure 5. Global Drug of Abuse (DOA) Testing Consumables Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug of Abuse (DOA) Testing Consumables Revenue in 2023
Figure 7. Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rapid Test Kits Picture
Figure 9. Assay Kits and Reagents Picture
Figure 10. Others Picture
Figure 11. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Drug of Abuse (DOA) Testing Consumables Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Laboratories
Figure 15. Product Picture of Workplace
Figure 16. Product Picture of At-Home
Figure 17. Product Picture of Others
Figure 18. Global Drug of Abuse (DOA) Testing Consumables Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Drug of Abuse (DOA) Testing Consumables Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Drug of Abuse (DOA) Testing Consumables Sales Value (%), (2019-2030)
Figure 31. United States Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 37. China Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 39. China Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 49. India Drug of Abuse (DOA) Testing Consumables Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Drug of Abuse (DOA) Testing Consumables Sales Value by Type (%), 2023 VS 2030
Figure 51. India Drug of Abuse (DOA) Testing Consumables Sales Value by Application (%), 2023 VS 2030
Figure 52. Drug of Abuse (DOA) Testing Consumables Industrial Chain
Figure 53. Drug of Abuse (DOA) Testing Consumables Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232